Daily Updates on Generic Entry, Litigation, Biosimilars, and more with the DrugPatentWatch Daily Briefing. Sign up… https://t.co/ep0KrikwZG
Archives
PlantForm CEO Dr. Don Stewart takes part in 2 sess
PlantForm CEO Dr. Don Stewart takes part in 2 sessions on #biosimilars @BIOKOREA June 9: Biosimilars in the COVID-1… https://t.co/9uXrTyhr9j
Loss of exclusivity and evolving regulatory stance
Loss of exclusivity and evolving regulatory stances are leading to an inflection point for biosimilars. https://t.co/dCcbuBwseI
Drug prices: the lucrative world of not-so-cheap i
Drug prices: the lucrative world of not-so-cheap imitations
But there are limits to the inroads that biosimilars c… https://t.co/Vzyvfv8dUO
A notable shift in demand from synthetic ingredien
A notable shift in demand from synthetic ingredients to biotech ingredients. Explore Why?
Download a FREE Sample P… https://t.co/1aDSfWSqvl
So lately my stomach hurts whenever I eat, which i
So lately my stomach hurts whenever I eat, which is the worst… like I could have broken a bone instead that would… https://t.co/lIYvAlzMhV
Treatment journey in rheumatoid arthritis with bio
Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost… https://t.co/7uCyYkLqPX
https://t.co/2hOkZ57w5B #7DaysAWeek #MultiPlayerGa
Crossing over from #biosimilars to novel biologics
Crossing over from #biosimilars to novel biologics – @CelltrionDream invests in @IksudaT
#Biopharma #Biotech https://t.co/gxf8oCrEcq
We have important regulatory changes in the health
We have important regulatory changes in the healthcare industry. For the most part, it simplifies an overloaded reg… https://t.co/p8fxRuRQtZ